479 results on '"Faughnan, Marie E."'
Search Results
2. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT
3. De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia
4. Quantification metrics for telangiectasia using optical coherence tomography
5. Pulmonary Vascular Manifestations of Hereditary Hemorrhagic Telangiectasia
6. Transarterial Embolization of Simple Pulmonary Arteriovenous Malformations: Long-Term Outcomes of 0.018-Inch Coils versus Vascular Plugs
7. Predictors of mortality in patients with hereditary hemorrhagic telangiectasia
8. Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations
9. Cyclo-oxygenase 2, a putative mediator of vessel remodeling, is expressed in the brain AVM vessels and associates with inflammation
10. Genotype-Phenotype Correlations in Children with HHT.
11. Assessing the Hereditary Hemorrhagic Telangiectasia Algorithms in a Community-Based Patient Population
12. Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia
13. Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia.
14. Surgical Treatment vs Nonsurgical Treatment for Brain Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study.
15. Endoglin deficiency impairs VEGFR2 but not FGFR1 or TIE2 activation and alters VEGF-mediated cellular responses in human primary endothelial cells
16. Persistent infiltration and pro-inflammatory differentiation of monocytes cause unresolved inflammation in brain arteriovenous malformation
17. Pre-operative embolization of a complex systemic to pulmonary vascular malformation
18. Supine vs upright exercise in patients with hepatopulmonary syndrome and orthodeoxia: study protocol for a randomized controlled crossover trial
19. Diagnostic Yield of Rescreening Adults for Pulmonary Arteriovenous Malformations
20. Reperfusion of Pulmonary Arteriovenous Malformations Following Embolotherapy: A Randomized Controlled Trial of Detachable Versus Pushable Coils
21. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
22. Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.
23. CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia
24. Decreased levels of miR-28-5p and miR-361-3p and increased levels of insulin-like growth factor 1 mRNA in mononuclear cells from patients with hereditary hemorrhagic telangiectasia
25. Brain Vascular Malformation Consortium: Overview, Progress and Future Directions.
26. Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: Gene–phenotype correlations
27. Antithrombotic Use Predicts Recanalization of Embolized Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia
28. An Analysis of Sex Differences in Pulmonary AVM Presentation, Complications, and Management in a Large, Multinational Registry of Patients With HHT
29. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
30. Prevalence and Characteristics of Intracranial Aneurysms in Hereditary Hemorrhagic Telangiectasia.
31. Pulmonary Vascular Manifestations of Hereditary Hemorrhagic Telangiectasia
32. Living donor liver transplant between physicians: two viewpoints
33. Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia
34. A theory for polymicrogyria and brain arteriovenous malformations in HHT
35. Prevalence and nature of dyspnea in patients with hereditary hemorrhagic telangiectasia (HHT)
36. 88 - Anomalías vasculares pulmonares
37. Neurovascular Complications and Pulmonary Arteriovenous Malformation Feeding Artery Size
38. Cumulative Radiation Dose in Patients With Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations
39. MicroRNA-132-3p, Downregulated in Myeloid Angiogenic Cells from Hereditary Hemorrhagic Telangiectasia Patients, Is Enriched in the TGFβ and PI3K/AKT Signalling Pathways
40. The use of anti-fibrinolytic agents in patients with HHT: a retrospective survey
41. 88 - Pulmonary Vascular Anomalies
42. A framework for applying unfamiliar trial designs in studies of rare diseases
43. Effects of Recipient Age and Diagnosis on Health-related Quality-of-Life Benefit of Lung Transplantation
44. Pulmonary Vascular Manifestations of Hereditary Hemorrhagic Telangiectasia
45. Embolization of Pulmonary Arteriovenous Malformations with Amplatzer Vascular Plugs: Safety and Midterm Effectiveness
46. Norfloxacin Therapy for Hepatopulmonary Syndrome: A Pilot Randomized Controlled Trial
47. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia
48. Embolization for Pulmonary Arteriovenous Malformation in Hereditary Hemorrhagic Telangiectasia: A Decision Analysis
49. Additional file 1 of Supine vs upright exercise in patients with hepatopulmonary syndrome and orthodeoxia: study protocol for a randomized controlled crossover trial
50. Additional file 1 of Predictors of mortality in patients with hereditary hemorrhagic telangiectasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.